Alternative pathway complement activation induces proinflammatory activity in human proximal tubular epithelial cells

Nephrology Dialysis Transplantation

Volumn 12, Issue 1, 1997, Pages 51-56

  David, S ^a   Biancone, L ^b   Caserta, C ^a   Bussolati, B ^a   Cambi, V ^a   Camussi, G ^b,c  

^a UNIVERSITY OF PARMA   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c Istituto di Nefro Urologia   (Italy)

Author keywords

Complement; Cytokine; Membrane attack complex; Proximal tubule; Tubular injury

Indexed keywords

ARACHIDONIC ACID; CALCIUM; CLASSICAL COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT MEMBRANE ATTACK COMPLEX; ICOSANOID; INTERLEUKIN 6; PHOSPHOLIPASE A2; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CALCIUM TRANSPORT; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT FIXATION; HUMAN; HUMAN CELL; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE CELL; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE;

ARACHIDONIC ACID; CALCIUM; COMPLEMENT PATHWAY, ALTERNATIVE; CYTOKINES; EPITHELIUM; GLOMERULONEPHRITIS; HUMANS; INFLAMMATION MEDIATORS; KIDNEY TUBULES, PROXIMAL;

EID: 0031013179     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/12.1.51     Document Type: Article

References (29)

1. Nath KA. Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis 1992; 20: 1-17
2. Ong ACM, Fine LG. Loss of glomerular function and tubulointerstitial fibrosis: cause or effect? Kidney Int 1994; 45: 345-351
3. Abbate M, Bertani T. New insights into the pathogenesis of tubulointerstiatial damage. In: Tetta C, ed 'Immunopharmacology of the Renal System'. Academic Press, London, 1994; 24-35
4. Camussi G, Tetta C, Mazzucco G, Vercellone A. The brush border of proximal tubules of normal human kidney activates the alternative pathway of the complement system in vitro. Ann. NY Acad Sci 1983; 420: 321-326
5. Camussi G, Rotunno M, Segoloni G, Brentjens JR, Andres GA. In vitro alternative pathway activation of complement by the brush border of proximal tubules of normal rat kidney. J Immunol 1982; 128: 1659-1663
6. Biancone L, David S, Della Pietra V, Montrucchio G, Cambi V, Camussi G. Alternative pathway activation of complement by cultured human proximal tubular epithelial cells. Kidney Int 1994; 45: 451-460
7. Eddy AA. Interstitial nephritis induced by protein overload proteinuria. Am J Pathol 1989; 135: 719-773
8. Bussolino F, Tessari F, Turrini F et al. Platelet activating factor induces dopamine release in PC-12 cell line. Am J Physiol 1988; 225: C559-565
9. Hirata F, Corcoran BA, Venkatasubramanian K, Schiffmann E, Axelroad J. Chemoattractants stimulate degradetion of methylated phospholipids and release of arachidonic acid in rabbit leukocytes. Proc Natl Acad Sci USA 1979; 76: 2640-2648
10. Volwerk IJ, Pieterson WA, Haas DC. Histidin at the active site of phospholipase A2. Biochemistry 1974; 13: 1446-1457
11. Baker PJ, Osofsky SG. Activation of human complement by heat-killed, human kidney cells grown in cell culture. J Immunol 1980; 124: 81-86
12. Baker PJ, Croker BP, Osofsky SG. Interactions of human, cultured kidney cells with the complement system. Kidney Int 1981; 20: 437-441
13. Baker PJ, Adler S, Yang Y, Couser WG. Complement activation by heat-killed human kidney cells: formation, activity, and stabilization of cell-bound C3 convertases. J Immunol 1984; 133: 877-881
14. Camussi G, Stratta P, Mazzucco G et al. In vivo localization of C3 on the brush border of proximal tubules of kidneys from nephrotic patients. Clin Nephrol 1985; 23: 134-141
15. Schulze M, Donadio JV, Pruchno CJ et al. Elevated urinary escretion of the C5b-9 complex in membranous nephropathy. Kidney Int 1991; 40: 533-538
16. Ogrodowski JL, Hebert LA, Sedmak D, Cosio FG, Tamerius J, Kolb W. Measurement of sC5b-9 in urine in patients with the nephrotic syndrome. Kidney Int 1991; 40: 1141-1147
17. Eddy AA, Michael AF. Acute tubulointerstitial nephritis associated with aminonucleoside nephrosis. Kidney Int 1988; 33: 14-23
18. Schulze M, Baker PJ, Perkinson DT et al. Increased urinary excretion of C5b-9 distinguishes passive Heymann nephritis in the rat. Kidney Int 1989; 35: 60-68
19. Vakeva A, Meri S, Lehto T, Laurila P. Activation of terminal complement cascade in renal infarction. Kidney Int 1995; 47: 918-926
20. Nath KA, Hostetter TH. Pathophysiology of chronic tubulointerstitial disease in rats: interactions of dietary acid load, ammonia, and complement component C3. J Clin Invest 1985; 76: 667-675
21. Brooimans RA, Stregman A, van Dorp WT et al. Interleukin 2 mediates stimulation of complement C3 biosynthesis in human proximal tubular epithelil cells. J Clin Invest 1991; 88: 379-384
22. Hansch GM. The complement attack phase: control of lysis and non-lethal effects of C5b-9. Immunopharmacology 1992; 24: 105-117
23. Hansch GM, Betz M, Gunther J, Rother KO, Sterzel B. Complement membrane attack complex stimulates the prostanoid production of cultured glomerular epithelial cells. Int Arch Allergy Appl Immunol 1988; 85: 87-93
24. Betz M, Hansch GM. Release of arachidonic acid a new function of the late complement components. Immunobiology 1984; 166: 473-479
25. Camussi G, Albano E, Tetta C, Bussolino F. Biology and molecular action of tumor necrosis factor-α (TNF-α). Eur J Biochem 1991; 202: 3-14
26. Hirano T, Akira S, Taga T, Kishimoto T. Biological and clinical aspects of IL-6. Immunol Today 1990; 11: 443-449
27. Lachmann PJ. The control of homologous lysis. Immunol Today 1991; 12: 312-315
28. Salmon JA, Higgs GA. The eicosanoids. In: Dale MM, Foreman JC, eds. Textbook of Immunopharmacology. Blackwell Scientific Publications, Oxford, 1989; 129-141
29. Ichida S, Yuzawa Y, Okada H, Yoshioka K, Matsuo S. Localization of the complement regulatory proteins in the normal human kidney. Kidney Int 1994; 46: 89-96